TBC
TBC
Validation Strategies for Pharmaceutical Patents in Europe
Special Report
The decision on where to validate a pharmaceutical European patent is a big one. With costs often precluding an “everywhere” approach for small- to medium-sized companies, research institutions and universities, it is necessary to choose from the long list of available countries. The choice typically factors in costs, business interests, likely markets and market size, possible manufacturing and import locations and the regulatory framework in Europe.
This report explores these choices and factors using publicly available data, seeking to answer questions such as:
- Which countries are most commonly picked by patent holders at the EPO?
- Is the distribution the same for pharmaceutical patents?
- Where does “big pharma” choose to validate?
- What factors might affect the choice of countries?
Read our blogs
UPC Weekly - Court of Appeal settles the UPC framework for inventive step
2025 Week 48 If you only read one UPC decision this year, read one of these. You can take your pick, based on technical background. Amgen v. Sanofi / Regeneron is in the field of antibodies for ...
.png)
UPC Weekly - Same parties, same prior art, same patent – different claim interpretations in the UPC and UK lead to different outcomes
2025 Week 47 We don’t often get to see the same patent being assessed in an EPO opposition, in the UK Patents Court and also at the Unified Patent Court. So we’ve lucked out with Advanced Cell ...
UPC Weekly - Have a second iron in the fire – hedging PI risk against the same medical device
2025 Week 46 The last month or so has seen a significant number of decisions on preliminary injunctions (PIs) for medical devices. What’s been noticeable about many of these cases is that they come ...
What does the UK Precision Breeding Act mean for Agriculture?
British agriculture reached a significant milestone on 13 November 2025, when the Genetic Technology (Precision Breeding) Regulations 2025 officially came into effect. In combination with the Genetic ...
UPC Weekly - UPC Court of Appeal brings order to the galaxy
2025 Week 45 This week we report on two recent and important UPC Court of Appeal decisions. Each considers claim interpretation and the relevance of expert and experimental evidence to UPC ...
UPC Weekly - File wrapper bites at the UPC
2025 Week 44 Claim interpretation at the UPC has been one of the most consistent threads through the decisions coming out of the first instance UPC courts, due in part to an early setting of the ...
Mewburn Ellis
FORWARD MAGAZINE
Mewburn Ellis Forward is a biannual publication that celebrates the best of innovation and exploration. Through its pages we hope to inform and entertain, but also to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial world. Along the way, we’ll engage with the IP challenges that international organisations face every day.